Chau Quang Khuong net worth and biography

Chau Khuong Biography and Net Worth

Chau Q. Khuong serves as Independent Director of the Company. He has served as a Private Equity Partner at OrbiMed Advisors LLC, a venture capital and asset management firm, since 2003. Mr. Khuong currently serves as a director of several publicly traded life sciences companies, including BELLUS Health Inc. since December 2018, Synlogic, Inc. since February 2016, Inspire Medical Systems, Inc. since May 2014 and Aerpio Pharmaceuticals, Inc. since April 2014, and previously served as a director of publicly traded biopharmaceutical companies Nabriva Therapeutics plc (formerly Nabriva Therapeutics AG) from April 2015 to August 2017 and Otonomy, Inc. from August 2013 to July 2016 and as chairman of the board of directors of biopharmaceutical company Pieris Pharmaceuticals, Inc. from December 2014 to November 2017. Mr. Khuong has also served on the board of directors for several privately held companies. Mr. Khuong received a B.S. in molecular biology with concentration in biotechnology and a M.P.H. with concentration in infectious diseases from Yale University.

How do I contact Chau Quang Khuong?: The corporate mailing address for Mr. Khuong and other Inspire Medical Systems executives is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. Inspire Medical Systems can also be reached via phone at (844) 672-4357 and via email at [email protected]. Learn More on Chau Quang Khuong's contact information.
Has Chau Quang Khuong been buying or selling shares of Inspire Medical Systems?: Chau Quang Khuong has not been actively trading shares of Inspire Medical Systems within the last three months. Most recently, Chau Quang Khuong sold 29,251 shares of the business's stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $109.93, for a transaction totalling $3,215,562.43. Learn More on Chau Quang Khuong's trading history.
Who are Inspire Medical Systems' active insiders?: Inspire Medical Systems' insider roster includes Randy Ban (Insider), Richard Buchholz (CFO), Philip Ebeling (COO), Jerry Griffin (Director), Timothy Herbert (CEO), Steven Jandrich (VP), Chau Khuong (Director), Georgia Melenikiotou (Director), Marilyn Nelson (Director), John Rondoni (CTO), and Casey Tansey (Director). Learn More on Inspire Medical Systems' active insiders.
Are insiders buying or selling shares of Inspire Medical Systems?: In the last year, insiders at the sold shares 12 times. They sold a total of 82,063 shares worth more than $16,763,484.79. The most recent insider tranaction occured on September, 9th when Director Shawn Mccormick sold 800 shares worth more than $176,000.00. Insiders at Inspire Medical Systems own 4.1% of the company. Learn More about insider trades at Inspire Medical Systems.
Information on this page was last updated on 9/9/2024.

Chau Quang Khuong Insider Trading History at Inspire Medical Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
8/13/2020	Sell	29,251	$109.93	$3,215,562.43
8/11/2020	Sell	116,570	$105.65	$12,315,620.50
3/6/2020	Sell	500,000	$83.52	$41,760,000.00
3/3/2020	Sell	75,000	$83.21	$6,240,750.00

Chau Quang Khuong Buying and Selling Activity at Inspire Medical Systems

Inspire Medical Systems Company Overview

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Today's Range

Now: $184.69

$182.14

$185.01

50 Day Range

MA: $200.19

$172.85

$216.71

2 Week Range

Now: $184.69

$123.00

$257.40

Volume

65,756 shs

Average Volume

597,359 shs

Market Capitalization

$5.54 billion

P/E Ratio

172.61

Dividend Yield

N/A

Beta

1.36

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.